WHO ICTRP trial

Multicenter randomized trial of the prevention of gastric mucosal injury with…

JPRN-UMIN000001316 · Japan Primary Registries Network (JPRN)

Key facts

Trial ID JPRN-UMIN000001316
Public title Multicenter randomized trial of the prevention of gastric mucosal injury with Rabeprazol in chemotherapeutic cases of pancreatic cancer
Scientific title Multicenter randomized trial of the prevention of gastric mucosal injury with Rabeprazol in chemotherapeutic cases of pancreatic cancer - G-RAP Test
Primary sponsor Faculty of Mediceine, University of Tokyo
Registry Japan Primary Registries Network (JPRN)
Study type Interventional
Phase Not applicable
Countries Japan
Conditions Pancreatic Cancer
Interventions A:Rabeprazole(10mg/Day)adiminisitration between 8weeks B:Without administration of any kind of PPI or H2RA
Registration date Aug 20, 2008
Target size 60
Registry page center6.umin.ac.jp

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations